India is launching a campaign to repair its reputation as a global supplier of cheap high-quality drugs, responding to bans imposed by U.S. Food and Drug Administration (FDA) on several suppliers, two top officials said on Tuesday. As part of the charm offensive, New Delhi has invited global Continue Reading
